Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma? Article

Clarke, Jennifer L, Ennis, Michele M, Yung, WK Alfred et al. (2011). Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma? . NEURO-ONCOLOGY, 13(10), 1118-1124. 10.1093/neuonc/nor110

Open Access

cited authors

  • Clarke, Jennifer L; Ennis, Michele M; Yung, WK Alfred; Chang, Susan M; Wen, Patrick Y; Cloughesy, Timothy F; DeAngelis, Lisa M; Robins, H Ian; Lieberman, Frank S; Fine, Howard A; Abrey, Lauren; Gilbert, Mark R; Mehta, Minesh; Kuhn, John G; Aldape, Kenneth D; Lamborn, Kathleen R; Prados, Michael D

sustainable development goals

authors

publication date

  • October 1, 2011

webpage

published in

keywords

  • Clinical Neurology
  • GLIOMA
  • II CLINICAL-TRIALS
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • PFS6
  • PHASE-II
  • Science & Technology
  • THERAPY
  • glioblastoma
  • prognosis
  • recurrence
  • surgery

Digital Object Identifier (DOI)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 1118

end page

  • 1124

volume

  • 13

issue

  • 10